US Broker Ratings

Teva Pharmaceutical Industries (TEVA) Rating Update: Assessing a Strong Buy Consensus Amidst a 22% Upside Potential

Teva Pharmaceutical Industries (NYSE: TEVA), a stalwart in the global healthcare arena, has long been a critical player in the specialty and generic drug manufacturing sector...

Stevanato Group S.p.A. (STVN) Stock Analysis: Unpacking a 19.97% Potential Upside for Savvy Investors

Stevanato Group S.p.A. (NYSE: STVN) is making waves in the healthcare sector, particularly in the Medical Instruments & Supplies industry. This Italy-based company, with a robust..

Insulet Corporation (PODD) Stock Analysis: Exploring a 15.3% Potential Upside with Robust Growth Prospects

Investors looking to capitalize on the growing demand for innovative medical devices might find Insulet Corporation (NASDAQ: PODD) an intriguing prospect. With a market capitalization of..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Exploring a 7.67% Potential Upside Amidst Strong Buy Ratings

For investors with an eye on the healthcare sector, iRhythm Technologies, Inc. (NASDAQ: IRTC) presents an intriguing opportunity, especially given the company’s dominant presence in the..

ResMed Inc. (RMD) Stock Analysis: Navigating a 7.83% Potential Upside Amid Healthcare Innovation

ResMed Inc. (NYSE: RMD), a prominent player in the Healthcare sector, operates within the Medical Instruments & Supplies industry, offering a robust portfolio of medical devices..

Qiagen N.V. (QGEN) Stock Analysis: Exploring a 10% Upside Potential in the Diagnostics Sector

Qiagen N.V. (NYSE: QGEN), a global leader in molecular diagnostics and research, offers investors an intriguing opportunity with a potential upside of 10.54%, according to current..

Gilead Sciences (GILD) Stock Analysis: Evaluating a 7.79% Upside Potential in the Healthcare Sector

Gilead Sciences, Inc. (NASDAQ: GILD), a leading player in the healthcare sector, has been at the forefront of biopharmaceutical innovation, particularly in areas of unmet medical..

Cardinal Health, Inc. (CAH) Stock Analysis: Exploring the 15.28% Upside Potential

Cardinal Health, Inc. (NYSE: CAH) stands out as a powerhouse in the healthcare sector. With a commanding market capitalization of $37.27 billion, the company is a..

Masimo Corporation (MASI) Stock Analysis: Exploring a 29.68% Potential Upside in Healthcare Innovation

Masimo Corporation (NASDAQ: MASI) is a significant player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $7.86 billion, Masimo..

Quest Diagnostics (DGX) Stock Analysis: Unveiling a 3.05% Potential Upside in the Healthcare Sector

Investors keeping an eye on the healthcare sector would do well to examine Quest Diagnostics Incorporated (NYSE: DGX), a significant player in the diagnostics and research..

Globus Medical, Inc. (GMED) Stock Analysis: 40% Potential Upside in the Healthcare Sector

Globus Medical, Inc. (NYSE: GMED), a prominent player in the healthcare sector, specifically within the medical devices industry, presents an intriguing opportunity for investors. With a..

Alkermes plc (ALKS) Stock Analysis: Investor Outlook with a 33.82% Potential Upside

For investors seeking opportunities in the healthcare sector, Alkermes plc (NASDAQ: ALKS) presents a compelling case. This Dublin-based biopharmaceutical company stands out with its focus on..

Vaxcyte, Inc. (PCVX) Stock Analysis: A Promising 143% Upside Potential for Biotech Investors

Vaxcyte, Inc. (NASDAQ: PCVX) has emerged as a focal point for investors seeking high-growth opportunities in the biotechnology sector. With its cutting-edge approach to vaccine development,..

Verona Pharma plc (VRNA) Stock Report: Evaluating the Potential of a Biotech Powerhouse with a $9.09 Billion Market Cap

Verona Pharma plc (NASDAQ: VRNA), a prominent player in the healthcare sector, is capturing investor attention with its substantial $9.09 billion market capitalization. As a biopharmaceutical..

Corcept Therapeutics (CORT) Stock Analysis: A Promising 82.87% Upside in the Biotech Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT) stands out in the biotechnology industry, promising significant growth potential amid its innovative therapeutic developments. The company, headquartered in Redwood City,..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 17.34% Potential Upside Amidst Healthcare Sector Dynamics

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, is capturing investor attention with its significant market presence and a potential upside of 17.34%,..

Cencora, Inc. (COR) Stock Analysis: Healthcare Giant’s Robust Growth and Strategic Positioning

Cencora, Inc. (NYSE: COR), a key player in the healthcare sector, has recently undergone significant changes that could position it for robust growth. Formerly known as..

Amgen Inc. (AMGN) Investor Outlook: Navigating a 7.42% Potential Upside Amidst Strong Revenue Growth

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, stands as a formidable player in the drug manufacturing industry. With a market capitalization of $156.19..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Balancing Robust Growth with Valuation Concerns

Medpace Holdings, Inc. (NASDAQ: MEDP), a pivotal player in the Healthcare sector’s Diagnostics & Research industry, commands attention with its impressive market cap of $14.08 billion...

Hologic, Inc. (HOLX) Stock Analysis: Exploring Growth Potential Amidst a 7.84% Upside

Hologic, Inc. (NASDAQ: HOLX) stands as a significant player in the healthcare sector, specializing in medical instruments and supplies with a core focus on women’s health...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds